UB Paderborn / Katalog / Suche / in CDI

Nuclear instruments & methods in physics research. Section A, Accelerators, spectrometers, detectors and associated equipment, 2016-08, Vol.827, p.102-106

2016

Link zum Volltext

Verfügbarkeit prüfen

Prediction of sound radiation from vibrating slender bodies by efficient integral methods

Gronberg, Fredrik

2000

Link zum Volltext

Verfügbarkeit prüfen

Prostate cancer screening in men aged 50–69 years (STHLM3): a prospective population-based diagnostic study

The lancet oncology, 2015-12, Vol.16 (16), p.1667-1676

2015

Link zum Volltext

Verfügbarkeit prüfen

Predictors of adverse pathology on radical prostatectomy specimen in men initially enrolled in active surveillance for low-risk prostate cancer

World journal of urology, 2021-06, Vol.39 (6), p.1797-1804

2021

Link zum Volltext

Verfügbarkeit prüfen

MRI-Targeted or Standard Biopsy in Prostate Cancer Screening

The New England journal of medicine, 2021-09, Vol.385 (10), p.908-920

2021

Link zum Volltext

Verfügbarkeit prüfen

Macrophage inhibitory cytokine‐1 (MIC‐1/GDF15): a new marker of all‐cause mortality

Aging cell, 2010-12, Vol.9 (6), p.1057-1064

2010

Link zum Volltext

Verfügbarkeit prüfen

Cost-Effectiveness of the Stockholm3 Test and Magnetic Resonance Imaging in Prostate Cancer Screening: A Microsimulation Study

European urology, 2022-07, Vol.82 (1), p.12-19

2022

Link zum Volltext

Verfügbarkeit prüfen

Prostate cancer screening using a combination of risk-prediction, MRI, and targeted prostate biopsies (STHLM3-MRI): a prospective, population-based, randomised, open-label, non-inferiority trial

The lancet oncology, 2021-09, Vol.22 (9), p.1240-1249

2021

Link zum Volltext

Verfügbarkeit prüfen

Macrophage Inhibitory Cytokine 1: A New Prognostic Marker in Prostate Cancer

Clinical cancer research, 2009-11, Vol.15 (21), p.6658-6664

2009

Link zum Volltext

Verfügbarkeit prüfen

Gene regulatory mechanisms underpinning prostate cancer susceptibility

Nature genetics, 2016-04, Vol.48 (4), p.387-397

2016

Link zum Volltext

Verfügbarkeit prüfen

Prostate Cancer Diagnostics Using a Combination of the Stockholm3 Blood Test and Multiparametric Magnetic Resonance Imaging

European urology, 2018-12, Vol.74 (6), p.722-728

2018

Link zum Volltext

Verfügbarkeit prüfen

Polygenic Risk Score Improves Prostate Cancer Risk Prediction: Results from the Stockholm-1 Cohort Study

European urology, 2011-07, Vol.60 (1), p.21-28

2011

Link zum Volltext

Verfügbarkeit prüfen

The Mitochondrial and Autosomal Mutation Landscapes of Prostate Cancer

European urology, 2013-04, Vol.63 (4), p.702-708

2013

Link zum Volltext

Verfügbarkeit prüfen

Interaction between Single Nucleotide Polymorphisms in Selenoprotein P and Mitochondrial Superoxide Dismutase Determines Prostate Cancer Risk

Cancer research (Chicago, Ill.), 2008-12, Vol.68 (24), p.10171-10177

2008

Link zum Volltext

Verfügbarkeit prüfen

Improved prostate cancer diagnostics with a structured pathway including »Stockholm 3« test, MRI and targeted perineal biopsies

Läkartidningen, 2023-08, Vol.120

2023

Link zum Volltext

Verfügbarkeit prüfen

Prostate Cancer IRE Study (PRIS): A Randomized Controlled Trial Comparing Focal Therapy to Radical Treatment in Localized Prostate Cancer

European urology open science (Online), 2023-05, Vol.51, p.89-94

2023

Link zum Volltext

Verfügbarkeit prüfen

Macrocyclic Prodrugs of a Selective Nonpeptidic Direct Thrombin Inhibitor Display High Permeability, Efficient Bioconversion but Low Bioavailability

Journal of medicinal chemistry, 2016-07, Vol.59 (14), p.6658-6670

2016

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 192

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(190)
Mit Volltextzugriff
(185)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Feasibility of unconstrained three-material decomposition: imaging an excised human heart using a prototype silicon photon-counting CT detector

Resolution characterization of a silicon-based, photon-counting computed tomography prototype capable of patient scanning

Bias–variance tradeoff in anticorrelated noise reduction for spectral CT

Count statistics of nonparalyzable photon‐counting detectors with nonzero pulse length

The effects of intra‐detector Compton scatter on low‐frequency DQE for photon‐counting CT using edge‐on‐irradiated silicon detectors

Constrained one-step material decomposition reconstruction of head CT data from a silicon photon-counting prototype

A method for geometric calibration of edge-on detectors in a CT-gantry

Compton Scatter Events Improve Both Density and Spectral Dose Efficiency in Edge-On-Irradiated Silicon Photon-Counting CT

Count rate performance of a silicon-strip detector for photon-counting spectral CT

Prediction of sound radiation from vibrating slender bodies by efficient integral methods

Prostate cancer screening in men aged 50–69 years (STHLM3): a prospective population-based diagnostic study

Predictors of adverse pathology on radical prostatectomy specimen in men initially enrolled in active surveillance for low-risk prostate cancer

MRI-Targeted or Standard Biopsy in Prostate Cancer Screening

Macrophage inhibitory cytokine‐1 (MIC‐1/GDF15): a new marker of all‐cause mortality

Cost-Effectiveness of the Stockholm3 Test and Magnetic Resonance Imaging in Prostate Cancer Screening: A Microsimulation Study

Prostate cancer screening using a combination of risk-prediction, MRI, and targeted prostate biopsies (STHLM3-MRI): a prospective, population-based, randomised, open-label, non-inferiority trial

Macrophage Inhibitory Cytokine 1: A New Prognostic Marker in Prostate Cancer

Gene regulatory mechanisms underpinning prostate cancer susceptibility

Prostate Cancer Diagnostics Using a Combination of the Stockholm3 Blood Test and Multiparametric Magnetic Resonance Imaging

Polygenic Risk Score Improves Prostate Cancer Risk Prediction: Results from the Stockholm-1 Cohort Study

The Mitochondrial and Autosomal Mutation Landscapes of Prostate Cancer

Interaction between Single Nucleotide Polymorphisms in Selenoprotein P and Mitochondrial Superoxide Dismutase Determines Prostate Cancer Risk

Improved prostate cancer diagnostics with a structured pathway including »Stockholm 3« test, MRI and targeted perineal biopsies

Prostate Cancer IRE Study (PRIS): A Randomized Controlled Trial Comparing Focal Therapy to Radical Treatment in Localized Prostate Cancer

Macrocyclic Prodrugs of a Selective Nonpeptidic Direct Thrombin Inhibitor Display High Permeability, Efficient Bioconversion but Low Bioavailability

Suchergebnisse filtern